HLB SCIENCE Inc. Logo

HLB SCIENCE Inc.

Develops drugs and diagnostics for infectious, immune, and Alzheimer's diseases.

343090 | KO

Overview

Corporate Details

ISIN(s):
KR7343090007
LEI:
Country:
South Korea
Address:
서울특별시 송파구 법원로 128씨동 1314호, 서울특별시

Description

HLB SCIENCE Inc. is a biopharmaceutical company specializing in the development of innovative drugs and diagnostics for infectious and immune-related diseases. The company's primary research focuses on creating therapeutics for sepsis, superbacteria infections, and Alzheimer's disease. Its key pipeline candidate for sepsis, DD-S052P, is a novel antibiotic designed to eliminate both bacteria and their associated endotoxins to mitigate cytokine storms. For Alzheimer's disease, HLB SCIENCE is advancing DD-A279, a treatment that modulates lipopolysaccharides (LPS) and gram-negative bacteria in the central nervous system. This therapeutic effort is complemented by the development of DD-A514, a diagnostic kit for the early detection of Alzheimer's.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
주주총회소집결의
Korean 7.2 KB
2025-09-17 00:00
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2025-09-17 00:00
[첨부추가]주요사항보고서(회사합병결정)
Korean 52.4 KB
2025-06-19 00:00
기업설명회(IR)개최결과
Korean 6.7 KB
2025-05-12 00:00
주식등의대량보유상황보고서(약식)
Korean 65.1 KB
2025-05-12 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-05-09 00:00
전환가액의조정 (제4회차)
Korean 10.1 KB
2025-04-23 00:00
본점소재지변경
Korean 5.0 KB
2025-03-25 00:00
정기주주총회결과
Korean 20.0 KB
2025-03-25 00:00
주식매수선택권부여에관한신고
Korean 16.6 KB
2025-03-17 00:00
감사보고서제출
Korean 9.7 KB
2025-03-17 00:00
사업보고서 (2024.12)
Korean 1022.1 KB
2025-03-10 00:00
주주총회소집공고
Korean 103.6 KB
2025-03-06 00:00
[기재정정]주식매수선택권부여에관한신고
Korean 23.8 KB
2025-03-06 00:00
주주총회소집결의
Korean 13.2 KB

Automate Your Workflow. Get a real-time feed of all HLB SCIENCE Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HLB SCIENCE Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HLB SCIENCE Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.